[1] |
Yoon JH, Lee HS, Kim E, et al.Malignancy risk stratification of thyroid nodules:comparison between the thyroid imaging reporting and data system and the 2014 American thyroid association management guidelines[J].Radiology, 2016, 278(3):917-24. doi: 10.1148/radiol.2015150056
|
[2] |
Gharib H, Papini E, Garber JR, et al.American association of clinical endocrinologists, American college of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules-2016 update[J].Endocr Pract, 2016, 22(Supplement 1):1-60. doi: 10.4158/EP161208.GL
|
[3] |
Haugen BR, Alexander EK, Bible KC, et al.2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J].Thyroid, 2016, 26(1):1-133. http://cn.bing.com/academic/profile?id=7d6a3b18d4b5e364f28a211695fe4501&encoded=0&v=paper_preview&mkt=zh-cn
|
[4] |
Woliński K, Szkudlarek M, Szczepanek-Parulska E, et al.Usefulness of different ultrasound features of malignancy in predicting the type of thyroid lesions:a meta-analysis of prospective studies[J].Pol Arch Intern Med, 2014, 124(3):97-104. doi: 10.20452/pamw.2132
|
[5] |
Noda Y, Kanematsu M, Goshima S, et al.MRI of the thyroid for differential diagnosis of benign thyroid nodules and papillary carcinomas[J].Am J Roentgenol, 2015, 204(3):W332-5. doi: 10.2214/AJR.14.13344
|
[6] |
Wang H, Wei R, Liu WY, et al.Diagnostic efficacy of multiple MRI parameters in differentiating benign vs.malignant thyroid nodules [J].BMC Med Imaging, 2018, 18:50-7. doi: 10.1186/s12880-018-0294-0
|
[7] |
Khizer AT, Raza S, Slehria A.Diffusion-weighted MR imaging and ADC mapping in differentiating benign from malignant thyroid nodules[J].J Coll Physicians Surg Pak, 2015, 25(11):785-8. http://cn.bing.com/academic/profile?id=fded8c6aab5de08a987b504315cdab91&encoded=0&v=paper_preview&mkt=zh-cn
|
[8] |
Azzedine B, Kahina MB, Dimitri P, et al.Whole-body diffusionweighted MRI for staging lymphoma at 3.0T:comparative study with MR imaging at 1.5T[J].Clin Imaging, 2015, 39(1):104-9. doi: 10.1016/j.clinimag.2014.06.017
|
[9] |
Tang YH, Wang HY, Wang YW, et al.Quantitative comparison of MR diffusion‐weighted imaging for liver focal lesions between 3.0T and 1.5T:Regions of interest of the minimum‐spot ADC, the largest possible solid part, and the maximum diameter in lesions[J].J Magn Reson Imaging, 2016, 44(5):1320-9. doi: 10.1002/jmri.25277
|
[10] |
Lu YG, Moreira AL, Hatzoglou V, et al.Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma:a novel tool for pre-operative risk stratification in thyroid cancer[J].Thyroid, 2015, 25(6):672-80. doi: 10.1089/thy.2014.0419
|
[11] |
Ito Y, Higashiyama T, Takamura Y, et al.Clinical outcomes of patients with papillary thyroid carcinoma after the detection of distant recurrence[J].World J Surg, 2010, 34(10):2333-7. doi: 10.1007/s00268-010-0712-0
|
[12] |
Maia ACM Jr, Guedes BVS, Lucas A Jr, et al.Diffusion MR imaging for monitoring treatment response[J].Neuroimaging Clin N Am, 2011, 21(1):153-78. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_ef1fe0494365af07e3721539e86e4d22
|
[13] |
Hao YH, Pan C, Chen WW, et al.Differentiation between malignant and benign thyroid nodules and stratification of papillary thyroid cancer with aggressive histological features:Whole-lesion diffusionweighted imaging histogram analysis[J].J Magn Reson Imaging, 2016, 44(6):1546-55. doi: 10.1002/jmri.25290
|
[14] |
谌业荣, 陆瑜, 单秀红, 等.指数表观扩散系数值定量分析在甲状腺结节良恶性鉴别中的应用[J].实用放射学杂志, 2018, 34(12):1849- 52. doi: 10.3969/j.issn.1002-1671.2018.12.007
|
[15] |
邓文明, 康文焱, 文洁, 等.对比水-脂分离成像技术与频率选择饱和法在头颈部增强MRI中的脂肪抑制效果[J].中国医学影像技术, 2018, 34(9):1390-4. http://d.old.wanfangdata.com.cn/Periodical/zgyxyxjs201809030
|
[16] |
尹秋凤, 张玉珍, 陈淑贤, 等.视网膜母细胞瘤中TSE-DWI与EP-DWI的相关性分析及临床应用价值[J].医学影像学杂志, 2018, 28(4): 554-7. http://d.old.wanfangdata.com.cn/Periodical/yxyxxzz201804013
|